B. Braun Medical Inc recalls Cefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System, 1 g in 50 mL duplex container, Fo
Recalled February 12, 2014 · FDA recall D-1054-2014 · B. Braun Medical
Hazard
Presence of Particulate Matter: The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit. · FDA Class I
Units
18,936 Containers
Sold at
Nationwide
Description
Presence of Particulate Matter: The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit.
Product
Cefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System, 1 g in 50 mL duplex container, For IV Use Only, Single Dose, Sterile/Non pyrogenic, Rx Only, B Braun Medical Inc., NDC 0264-3193-11
Manufacturer(s)
B. Braun Medical Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →